Medopharm
⚠️ Moderate Risk
FEI: 3008173089 • Chennai, Tamil Nadu • INDIA
FEI Number
3008173089
Location
Chennai, Tamil Nadu
Country
INDIAAddress
2nd Floor, A - 4 "Parsn Manere" 602, Chennai, Tamil Nadu, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/2/2015 | 56IAY76AZITHROMYCIN (MACAROLIDES) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/2/2015 | 61WAY45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/2/2015 | 56ECY22DOXYCYCLINE HYCLATE (TETRACYCLINES) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/2/2010 | 66SAA27NIFEDIPINE (VASODILATOR) | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Medopharm's FDA import refusal history?
Medopharm (FEI: 3008173089) has 4 FDA import refusal record(s) in our database, spanning from 6/2/2010 to 12/2/2015.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Medopharm's FEI number is 3008173089.
What types of violations has Medopharm received?
Medopharm has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Medopharm come from?
All FDA import refusal data for Medopharm is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.